US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017.
Objectives. To estimate the number of US emergency department visits for prescription opioid harms by patient characteristics, intent, clinical manifestations, and active ingredient. Methods. We used data from medical record–based surveillance from a nationally representative 60-hospital sample. Res...
| Published in: | American Journal of Public Health Vol. 109; no. 5; pp. 784 - 792 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Published: |
American Public Health Association
May2019
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=135849120&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 135849120 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00900036 APH jtl: American Journal of Public Health issn: 00900036 maglogo: N pubinfo: dt: May2019 vid: 109 iid: 5 pid: 44 pub: American Public Health Association artinfo: ui: 135849120 10.2105/AJPH.2019.305007 ppf: 784 ppct: 8 formats: tig: atl: US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017. aug: au: Lovegrove, Maribeth C. Dowell, Deborah Geller, Andrew I. Goring, Sandra K. Rose, Kathleen O. Weidle, Nina J. Budnitz, Daniel S. su: United States Alcohol drinking Drugs Drugs of abuse Narcotics Oxycodone Analgesics Confidence intervals Drug overdose Hospital emergency services Medical appointments Medical records Descriptive statistics sug: subj: Alcohol drinking Drugs Drugs of abuse Narcotics Oxycodone United States Pharmaceutical and medicine manufacturing Drinking Places (Alcoholic Beverages) Pharmaceuticals and pharmacy supplies merchant wholesalers Drugs and Druggists' Sundries Merchant Wholesalers Analgesics Confidence intervals Drug overdose Hospital emergency services Medical appointments Medical records Descriptive statistics ab: Objectives. To estimate the number of US emergency department visits for prescription opioid harms by patient characteristics, intent, clinical manifestations, and active ingredient. Methods. We used data from medical record–based surveillance from a nationally representative 60-hospital sample. Results. Based on 7769 cases, there were 267 020 estimated emergency department visits annually (95% confidence interval [CI] = 209 833, 324 206) for prescription opioid harms from 2016 to 2017. Nearly half of visits (47.6%; 95% CI = 40.8%, 54.4%) were attributable to nonmedical opioid use, 38.9% (95% CI = 32.9%, 44.8%) to therapeutic use, and 13.5% (95% CI = 11.0%, 16.0%) to self-harm. Co-implication with other pharmaceuticals and concurrent illicit drug and alcohol use were common; prescription opioids alone were implicated in 31.5% (95% CI = 27.2%, 35.8%) of nonmedical use visits and 19.7% (95% CI = 15.7%, 23.7%) of self-harm visits. Unresponsiveness or cardiorespiratory failure (30.0%) and altered mental status (35.7%) were common in nonmedical use visits. Gastrointestinal effects (30.4%) were common in therapeutic use visits. Oxycodone was implicated in more than one third of visits across intents. Conclusions. Morbidity data can help target interventions, such as dispensing naloxone to family and friends of those with serious overdose, and screening and treatment of substance use disorder when opioids are prescribed long-term. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|